Vanguard Group Inc Rani Therapeutics Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 709,828 shares of RANI stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
709,828
Previous 685,303
3.58%
Holding current value
$1.71 Million
Previous $2.13 Million
26.56%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RANI
# of Institutions
38Shares Held
2.95MCall Options Held
2KPut Options Held
3.1K-
Nan Fung Group Holdings LTD Central, K3494KShares$1.19 Million2.18% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$1.08 Million0.11% of portfolio
-
United Services Automobile Association San Antonio, TX312KShares$752,1480.03% of portfolio
-
Geode Capital Management, LLC Boston, MA151KShares$363,2680.0% of portfolio
-
Stifel Financial Corp St. Louis, MO135KShares$324,4340.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $59M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...